Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide reduces appetite significantly, and that creates a real decision for anyone who trains: how do you keep lifting, progressing and protecting muscle when your calorie intake drops? The short answer is that weight training and semaglutide work well together — but the combination calls for deliberate choices around protein, load and recovery that passive weight loss alone does not. Semaglutide is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When appetite falls sharply, energy availability tends to follow. That's the central tension for anyone combining wegovy training with a structured lifting programme. The question isn't whether you should train (you should) it's whether your nutrition and recovery are calibrated to support it.
Resistance training during a calorie deficit preserves lean mass in a way that cardio alone cannot. The mechanical signal to your muscles (load against resistance) tells the body those tissues are worth keeping. Without that signal, a significant proportion of weight lost during any aggressive calorie restriction can come from muscle rather than fat. On semaglutide, where appetite suppression can be pronounced, that risk is amplified if training is dropped or intensity falls too far.
The practical decision, then, is to treat your lifting programme as non-negotiable and adjust nutrition around it, not the other way around. Our overview of semaglutide covers how the medicine works mechanically, which is useful context for understanding why energy and fullness cues shift the way they do.
Most people on semaglutide report eating noticeably less. What the medicine doesn't do is sort that reduction usefully, it simply reduces appetite, so portions shrink across the board. For someone training three or four times a week, that often means protein intake drops below what muscle preservation needs, quietly and without obvious symptoms until recovery starts to suffer.
The broadly accepted target for people in a calorie deficit who train is around 1.6–2.2g of protein per kilogram of bodyweight daily. That figure doesn't change because you're on semaglutide; if anything, it becomes harder to hit. Lean proteins (chicken, fish, eggs, Greek yoghurt, cottage cheese) are worth prioritising at the start of each meal while appetite is still present, before fullness sets in. If you train in the morning, fitting your protein shake into your gym bag the night before means it's there even if breakfast feels unappealing.
People who find themselves gaining weight despite being on treatment sometimes trace it to muscle gain alongside fat loss, a picture that looks confusing on the scales, and our guide to gaining weight on Wegovy addresses that scenario in detail, including what the scales may not be telling you.
The first four to eight weeks on semaglutide are an adjustment period. Nausea, fatigue and reduced appetite are most common during dose escalation, and training at previous intensity levels can feel disproportionately hard. This is temporary for most people, but it does need a plan.
Dropping volume moderately (fewer sets per session rather than abandoning sessions) is a practical middle ground. Keeping frequency up (getting to the gym three times rather than twice, even for shorter sessions) preserves the muscle-retention signal better than grinding through a full programme while under-fuelled. As the GI side effects settle, volume can climb back up.
Compound lifts (squats, deadlifts, rows, presses) are more efficient per training minute than isolation work, which matters when session length shrinks. Progressive overload, adding small increments of weight or an extra rep over several weeks, continues to matter even when the numbers move slowly. Stalling on load is fine; the signal to retain muscle is still there.
The Wegovy treatment page covers what the titration schedule looks like, which can help you anticipate when the adjustment phase is likely to ease.
The STEP 1 trial, published in the New England Journal of Medicine, showed around 15% average body-weight reduction over 68 weeks with semaglutide 2.4mg alongside lifestyle intervention. Participants were not required to follow a specific resistance-training programme, which is a real limitation for anyone trying to draw conclusions about muscle preservation specifically. The trial measured total weight and BMI; lean mass composition was a secondary consideration.
What the wider literature does support clearly is that resistance training combined with a calorie deficit consistently produces better lean-mass retention than a deficit alone. For semaglutide users, this means the medicine handles appetite suppression while structured lifting handles the muscle-retention side, neither does the other's job.
NHS guidance on semaglutide notes that lifestyle changes, including physical activity, are recommended alongside treatment. The type and structure of that activity is a conversation worth having with your prescriber, particularly if you're training competitively or returning from injury.
If you want to understand whether semaglutide treatment is right for your situation, checking your eligibility with our clinical team is the place to start. Clinicians looking to build their own knowledge in this area may find it useful to explore our semaglutide training course for UK practitioners, including options for a semaglutide training course available online free. Our lead prescriber oversees every consultation personally. There's no algorithm involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.